OptimizeRx Corporation increased earnings guidance for the year 2023. For the year, the company now expects revenue to be between $68 million and $70 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.19 USD | +2.72% | +2.21% | -28.79% |
Jun. 05 | Transcript : OptimizeRx Corporation - Shareholder/Analyst Call | |
May. 15 | Tranche Update on OptimizeRx Corporation's Equity Buyback Plan announced on March 14, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.79% | 186M | |
+33.01% | 279B | |
+17.65% | 151B | |
+7.82% | 93.18B | |
+27.35% | 91.61B | |
+60.86% | 60.17B | |
+6.18% | 42.94B | |
+17.43% | 35.53B | |
-13.27% | 30.96B | |
+11.47% | 28.21B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- OptimizeRx Corporation Increases Earnings Guidance for the Year 2023